Cargando…

Serum CA19-9 as a Predictor of Malignancy in Primary Ovarian Mucinous Tumors: A Matched Case-Control Study

BACKGROUND: This study was designed to investigate the clinical characteristics correlated with serum CA19-9 elevation in primary mucinous ovarian tumors and to evaluate the role of serum CA19-9 in predicting borderline or malignant tumors. MATERIAL/METHODS: We retrospectively identified 27 women wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hye-yon, Kyung, Min Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117678/ https://www.ncbi.nlm.nih.gov/pubmed/25073801 http://dx.doi.org/10.12659/MSM.890954

Ejemplares similares

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

CA19-9 elevation in ovarian mature cystic teratoma: Discrimination from ovarian cancer – CA19-9 level in teratoma
por: Cho, Hye-yon, et al.
Publicado: (2013)

The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors
por: de Lacerda Almeida, Bernardo Gomes, et al.
Publicado: (2014)

Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
por: Cho, Hye Yon, et al.
Publicado: (2015)

EGFR Immunoexpression in Malignant Serous and Mucinous Ovarian Tumors
por: CÎRSTEA, A.E., et al.
Publicado: (2018)

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas
por: Deng, Shengming, et al.
Publicado: (2020)

A giant ovarian mucinous tumor in a 58-year-old postmenopausal patient with persistent abdominal pain and high serum levels of CA 19-9
por: Mulita, Francesk, et al.
Publicado: (2020)

Ovarian Mixed Malignant Brenner-Mucinous Tumor with Signet Ring Cells
por: Khadang, Baharak, et al.
Publicado: (2020)

Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor
por: Zhang, Wen, et al.
Publicado: (2018)

Solitary Colorectal Metastasis from a Mucin-rich Ovarian Tumor
por: Utsumi, Takahiro, et al.
Publicado: (2019)

Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19–9: a case report and review of literature
por: Choi, Won Ku, et al.
Publicado: (2019)

Misdiagnosed appendiceal mucinous neoplasms and primary ovarian mucinous tumors present with different pre- and intraoperative characteristics
por: Yu, Yi, et al.
Publicado: (2022)

The Serum CA-125 Concentration Data Assists in Evaluating CT Imaging Information When Used to Differentiate Borderline Ovarian Tumor from Malignant Epithelial Ovarian Tumors
por: Shin, Ji-Eun, et al.
Publicado: (2011)

Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma
por: Tian, Qifang, et al.
Publicado: (2016)

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
por: Anton, Cristina, et al.
Publicado: (2012)

Role of magnetic resonance imaging in the differentiation of mucinous ovarian carcinoma and mucinous borderline ovarian tumors
por: Hasbay, Ebru, et al.
Publicado: (2023)

Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma
por: He, Xiaoli, et al.
Publicado: (2023)

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
por: Ebeling, F G, et al.
Publicado: (2002)

Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors
por: Chen, Fawen, et al.
Publicado: (2018)

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer
por: Zhang, Wei, et al.
Publicado: (2018)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Swyer's Syndrome with Mixed Ovarian Malignant Germ Cell Tumor and Ovarian Gonadoblastoma
por: Zhu, Hong-Lan, et al.
Publicado: (2016)

Low-Grade Appendiceal Mucinous Neoplasm (LAMN) Primarily Diagnosed as an Ovarian Mucinous Tumor
por: Perivoliotis, Konstantinos, et al.
Publicado: (2021)

Ultrasonic and pathological characteristics of ovarian mucinous cystic tumors with malignant mural nodules: Two cases report
por: Zhang, Yan, et al.
Publicado: (2017)

Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors
por: Dolivet, Enora, et al.
Publicado: (2023)

Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study
por: Lin, Wei, et al.
Publicado: (2018)

Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis
por: Hada, Taira, et al.
Publicado: (2021)

THE ROLE OF SALIVARY AND SERUM CA125 AND ROUTINE BLOOD TESTS IN PATIENTS WITH OVARIAN MALIGNANCIES
por: Vuković, Ante, et al.
Publicado: (2021)

Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant
por: Liu, Wei, et al.
Publicado: (2018)

A Primary Retroperitoneal Mucinous Tumor
por: Heelan Gladden, Alicia A., et al.
Publicado: (2015)

Mucin
Publicado: (1905)

Primary squamous cell carcinoma of the ovary accompanied by transition of a mucinous borderline ovarian tumor
por: Bak, Seungeun, et al.
Publicado: (2023)

CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis
por: Cho, Hye-yon, et al.
Publicado: (2019)

Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study
por: Sun, Yan-wu, et al.
Publicado: (2017)

A novel algorithm for better distinction of primary mucinous ovarian carcinomas and mucinous carcinomas metastatic to the ovary
por: Simons, Michiel, et al.
Publicado: (2019)

Decreased Gastric Gland Mucin-specific O-glycans Are Involved in the Progression of Ovarian Primary Mucinous Tumours
por: Ohya, Ayumi, et al.
Publicado: (2021)

Coexistence of malignant ovarian Brenner tumor and borderline mucinous cystadenoma, combined with primary uterine corpus endometrioid carcinoma: A case report and literature review
por: Zou, Cancan, et al.
Publicado: (2022)

Primary Retroperitoneal Mucinous Cystic Tumors with Borderline Malignancy: A Case Report and Literature Review
por: Manrai, Megumi, et al.
Publicado: (2015)

Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours
por: Wang, Fujun, et al.
Publicado: (2023)

Mucinous tumors arising from ovarian teratomas as another source of pseudomyxoma peritoneii: MR findings comparison with ovarian metastases from appendiceal mucinous tumors
por: Tanaka, Yumiko Oishi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2dms1tv822aalvv0bev4cu35qg